3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells
Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarco...
Gespeichert in:
Veröffentlicht in: | Journal of molecular medicine (Berlin, Germany) Germany), 2021-03, Vol.99 (3), p.425-438 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 438 |
---|---|
container_issue | 3 |
container_start_page | 425 |
container_title | Journal of molecular medicine (Berlin, Germany) |
container_volume | 99 |
creator | Dubich, Tatyana Dittrich, Anne Bousset, Kristine Geffers, Robert Büsche, Guntram Köster, Mario Hauser, Hansjörg Schulz, Thomas F. Wirth, Dagmar |
description | Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarcoma the majority of spindle cells are KSHV-infected, viral copies are rapidly lost in vitro, both upon culture of tumor-derived cells or from newly infected endothelial cells. We addressed this discrepancy by investigating a KSHV-infected endothelial cell line in various culture conditions and in tumors of xenografted mice. We show that, in contrast to two-dimensional endothelial cell cultures, KSHV genomes are maintained under 3D cell culture conditions and in vivo. Additionally, an increased rate of newly infected cells was detected in 3D cell culture. Furthermore, we show that the PI3K/Akt/mTOR and ATM/γH2AX pathways are modulated and support an improved KSHV persistence in 3D cell culture. These mechanisms may contribute to the persistence of KSHV in tumor tissue in vivo and provide a novel target for KS specific therapeutic interventions.
Key messages
In vivo maintenance of episomal KSHV can be mimicked in 3D spheroid cultures
3D maintenance of KSHV is associated with an increased de novo infection frequency
PI3K/Akt/mTOR and ATM/ γH2AX pathways contribute to viral maintenance |
doi_str_mv | 10.1007/s00109-020-02020-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7900040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480493154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-84d74793a2cec996af174050285fee6fddb4ddeb319965f8c510ecbd1dd3e50d3</originalsourceid><addsrcrecordid>eNp9kUtuFDEQhi0EIkPgAiyQJTZh0VB-9HR7g4QSICiRWPDYWh67OuOo227sdiR2uQbX4yR4mBAeCxa2paqvflfVT8hjBs8ZQPciAzBQDXDYnXr3d8iKScEbJiXcJStQct3wjq0PyIOcLyvetUreJwdCyF7ynq1IESfUlnEpCamNwfnFx5BpLvMc00LPzByz_379rYZMsnEydItpxnzlU8n06OzD6edndDI-LBhMsEhNcLQmzUjznNA46gPF4OKyxdHXqMVxzA_JvcGMGR_dvIfk05vXH49Pm_P3b98dvzpvrOzk0vTSdbJTwnCLVqm1GVgnoQXetwPienBuI53DjWA12Q69bRmg3TjmnMAWnDgkL_e6c9lM6CyGpXam5-Qnk77qaLz-OxP8Vl_EK90pAJBQBY5uBFL8UjAvevJ5N4IJGEvWXPYglWCtrOjTf9DLWFKo41VKccZ53X6l-J6yKeaccLhthoHeuar3rurqp_7pqu5r0ZM_x7gt-WVjBcQeqDv34QLT77__I_sDw_Kwfw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2492122175</pqid></control><display><type>article</type><title>3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells</title><source>SpringerLink Journals</source><creator>Dubich, Tatyana ; Dittrich, Anne ; Bousset, Kristine ; Geffers, Robert ; Büsche, Guntram ; Köster, Mario ; Hauser, Hansjörg ; Schulz, Thomas F. ; Wirth, Dagmar</creator><creatorcontrib>Dubich, Tatyana ; Dittrich, Anne ; Bousset, Kristine ; Geffers, Robert ; Büsche, Guntram ; Köster, Mario ; Hauser, Hansjörg ; Schulz, Thomas F. ; Wirth, Dagmar</creatorcontrib><description>Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarcoma the majority of spindle cells are KSHV-infected, viral copies are rapidly lost in vitro, both upon culture of tumor-derived cells or from newly infected endothelial cells. We addressed this discrepancy by investigating a KSHV-infected endothelial cell line in various culture conditions and in tumors of xenografted mice. We show that, in contrast to two-dimensional endothelial cell cultures, KSHV genomes are maintained under 3D cell culture conditions and in vivo. Additionally, an increased rate of newly infected cells was detected in 3D cell culture. Furthermore, we show that the PI3K/Akt/mTOR and ATM/γH2AX pathways are modulated and support an improved KSHV persistence in 3D cell culture. These mechanisms may contribute to the persistence of KSHV in tumor tissue in vivo and provide a novel target for KS specific therapeutic interventions.
Key messages
In vivo maintenance of episomal KSHV can be mimicked in 3D spheroid cultures
3D maintenance of KSHV is associated with an increased de novo infection frequency
PI3K/Akt/mTOR and ATM/ γH2AX pathways contribute to viral maintenance</description><identifier>ISSN: 0946-2716</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/s00109-020-02020-8</identifier><identifier>PMID: 33484281</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>1-Phosphatidylinositol 3-kinase ; AKT protein ; Biomedical and Life Sciences ; Biomedicine ; Cell culture ; Effusion ; Endothelial cells ; Genomes ; Human Genetics ; Internal Medicine ; Kaposi's sarcoma ; Kaposis sarcoma ; Molecular Medicine ; Original ; Original Article ; Primary effusion lymphoma ; Sarcoma ; Therapeutic applications ; TOR protein ; Tumors ; Xenografts</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 2021-03, Vol.99 (3), p.425-438</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-84d74793a2cec996af174050285fee6fddb4ddeb319965f8c510ecbd1dd3e50d3</citedby><cites>FETCH-LOGICAL-c474t-84d74793a2cec996af174050285fee6fddb4ddeb319965f8c510ecbd1dd3e50d3</cites><orcidid>0000-0002-2541-6251</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00109-020-02020-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00109-020-02020-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33484281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubich, Tatyana</creatorcontrib><creatorcontrib>Dittrich, Anne</creatorcontrib><creatorcontrib>Bousset, Kristine</creatorcontrib><creatorcontrib>Geffers, Robert</creatorcontrib><creatorcontrib>Büsche, Guntram</creatorcontrib><creatorcontrib>Köster, Mario</creatorcontrib><creatorcontrib>Hauser, Hansjörg</creatorcontrib><creatorcontrib>Schulz, Thomas F.</creatorcontrib><creatorcontrib>Wirth, Dagmar</creatorcontrib><title>3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med</addtitle><addtitle>J Mol Med (Berl)</addtitle><description>Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarcoma the majority of spindle cells are KSHV-infected, viral copies are rapidly lost in vitro, both upon culture of tumor-derived cells or from newly infected endothelial cells. We addressed this discrepancy by investigating a KSHV-infected endothelial cell line in various culture conditions and in tumors of xenografted mice. We show that, in contrast to two-dimensional endothelial cell cultures, KSHV genomes are maintained under 3D cell culture conditions and in vivo. Additionally, an increased rate of newly infected cells was detected in 3D cell culture. Furthermore, we show that the PI3K/Akt/mTOR and ATM/γH2AX pathways are modulated and support an improved KSHV persistence in 3D cell culture. These mechanisms may contribute to the persistence of KSHV in tumor tissue in vivo and provide a novel target for KS specific therapeutic interventions.
Key messages
In vivo maintenance of episomal KSHV can be mimicked in 3D spheroid cultures
3D maintenance of KSHV is associated with an increased de novo infection frequency
PI3K/Akt/mTOR and ATM/ γH2AX pathways contribute to viral maintenance</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>AKT protein</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell culture</subject><subject>Effusion</subject><subject>Endothelial cells</subject><subject>Genomes</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Kaposi's sarcoma</subject><subject>Kaposis sarcoma</subject><subject>Molecular Medicine</subject><subject>Original</subject><subject>Original Article</subject><subject>Primary effusion lymphoma</subject><subject>Sarcoma</subject><subject>Therapeutic applications</subject><subject>TOR protein</subject><subject>Tumors</subject><subject>Xenografts</subject><issn>0946-2716</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtuFDEQhi0EIkPgAiyQJTZh0VB-9HR7g4QSICiRWPDYWh67OuOo227sdiR2uQbX4yR4mBAeCxa2paqvflfVT8hjBs8ZQPciAzBQDXDYnXr3d8iKScEbJiXcJStQct3wjq0PyIOcLyvetUreJwdCyF7ynq1IESfUlnEpCamNwfnFx5BpLvMc00LPzByz_379rYZMsnEydItpxnzlU8n06OzD6edndDI-LBhMsEhNcLQmzUjznNA46gPF4OKyxdHXqMVxzA_JvcGMGR_dvIfk05vXH49Pm_P3b98dvzpvrOzk0vTSdbJTwnCLVqm1GVgnoQXetwPienBuI53DjWA12Q69bRmg3TjmnMAWnDgkL_e6c9lM6CyGpXam5-Qnk77qaLz-OxP8Vl_EK90pAJBQBY5uBFL8UjAvevJ5N4IJGEvWXPYglWCtrOjTf9DLWFKo41VKccZ53X6l-J6yKeaccLhthoHeuar3rurqp_7pqu5r0ZM_x7gt-WVjBcQeqDv34QLT77__I_sDw_Kwfw</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Dubich, Tatyana</creator><creator>Dittrich, Anne</creator><creator>Bousset, Kristine</creator><creator>Geffers, Robert</creator><creator>Büsche, Guntram</creator><creator>Köster, Mario</creator><creator>Hauser, Hansjörg</creator><creator>Schulz, Thomas F.</creator><creator>Wirth, Dagmar</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2541-6251</orcidid></search><sort><creationdate>20210301</creationdate><title>3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells</title><author>Dubich, Tatyana ; Dittrich, Anne ; Bousset, Kristine ; Geffers, Robert ; Büsche, Guntram ; Köster, Mario ; Hauser, Hansjörg ; Schulz, Thomas F. ; Wirth, Dagmar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-84d74793a2cec996af174050285fee6fddb4ddeb319965f8c510ecbd1dd3e50d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>AKT protein</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell culture</topic><topic>Effusion</topic><topic>Endothelial cells</topic><topic>Genomes</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Kaposi's sarcoma</topic><topic>Kaposis sarcoma</topic><topic>Molecular Medicine</topic><topic>Original</topic><topic>Original Article</topic><topic>Primary effusion lymphoma</topic><topic>Sarcoma</topic><topic>Therapeutic applications</topic><topic>TOR protein</topic><topic>Tumors</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubich, Tatyana</creatorcontrib><creatorcontrib>Dittrich, Anne</creatorcontrib><creatorcontrib>Bousset, Kristine</creatorcontrib><creatorcontrib>Geffers, Robert</creatorcontrib><creatorcontrib>Büsche, Guntram</creatorcontrib><creatorcontrib>Köster, Mario</creatorcontrib><creatorcontrib>Hauser, Hansjörg</creatorcontrib><creatorcontrib>Schulz, Thomas F.</creatorcontrib><creatorcontrib>Wirth, Dagmar</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubich, Tatyana</au><au>Dittrich, Anne</au><au>Bousset, Kristine</au><au>Geffers, Robert</au><au>Büsche, Guntram</au><au>Köster, Mario</au><au>Hauser, Hansjörg</au><au>Schulz, Thomas F.</au><au>Wirth, Dagmar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><stitle>J Mol Med</stitle><addtitle>J Mol Med (Berl)</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>99</volume><issue>3</issue><spage>425</spage><epage>438</epage><pages>425-438</pages><issn>0946-2716</issn><eissn>1432-1440</eissn><abstract>Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarcoma the majority of spindle cells are KSHV-infected, viral copies are rapidly lost in vitro, both upon culture of tumor-derived cells or from newly infected endothelial cells. We addressed this discrepancy by investigating a KSHV-infected endothelial cell line in various culture conditions and in tumors of xenografted mice. We show that, in contrast to two-dimensional endothelial cell cultures, KSHV genomes are maintained under 3D cell culture conditions and in vivo. Additionally, an increased rate of newly infected cells was detected in 3D cell culture. Furthermore, we show that the PI3K/Akt/mTOR and ATM/γH2AX pathways are modulated and support an improved KSHV persistence in 3D cell culture. These mechanisms may contribute to the persistence of KSHV in tumor tissue in vivo and provide a novel target for KS specific therapeutic interventions.
Key messages
In vivo maintenance of episomal KSHV can be mimicked in 3D spheroid cultures
3D maintenance of KSHV is associated with an increased de novo infection frequency
PI3K/Akt/mTOR and ATM/ γH2AX pathways contribute to viral maintenance</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33484281</pmid><doi>10.1007/s00109-020-02020-8</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-2541-6251</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0946-2716 |
ispartof | Journal of molecular medicine (Berlin, Germany), 2021-03, Vol.99 (3), p.425-438 |
issn | 0946-2716 1432-1440 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7900040 |
source | SpringerLink Journals |
subjects | 1-Phosphatidylinositol 3-kinase AKT protein Biomedical and Life Sciences Biomedicine Cell culture Effusion Endothelial cells Genomes Human Genetics Internal Medicine Kaposi's sarcoma Kaposis sarcoma Molecular Medicine Original Original Article Primary effusion lymphoma Sarcoma Therapeutic applications TOR protein Tumors Xenografts |
title | 3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T10%3A02%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=3D%20culture%20conditions%20support%20Kaposi%E2%80%99s%20sarcoma%20herpesvirus%20(KSHV)%20maintenance%20and%20viral%20spread%20in%20endothelial%20cells&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=Dubich,%20Tatyana&rft.date=2021-03-01&rft.volume=99&rft.issue=3&rft.spage=425&rft.epage=438&rft.pages=425-438&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/s00109-020-02020-8&rft_dat=%3Cproquest_pubme%3E2480493154%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2492122175&rft_id=info:pmid/33484281&rfr_iscdi=true |